Business Paid
Captor Therapeutics with PLN 35.89 mln loss in 2022
18:14
Captor Therapeutics, a Polish biotechnology company, reported a consolidated net loss of PLN 35.89 million ($8.8 million) for 2022, up from PLN 32.57 million ($7.9 million) in the previous year. The company's operating loss for 2022 was PLN 38.36 million ($9.4 million), compared to PLN 31.71 million ($7.7 million) in 2021.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
